XNAS · FLGT
+1.31% · +$0.2700 · Vol 249.6K
Market closed · last close 4:00 PM ET · price as of 16:01:19 ET
Fulgent Genetics, Inc. Common Stock

Fulgent Genetics, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$20.88

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is FLGT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for FLGT are being assembled.
About Fulgent Genetics, Inc. Common Stock
SERVICES-MEDICAL LABORATORIES
Listed since
2016
Employees
1K
Country
US

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$20.50
Day high
$20.97
Day low
$20.31
Previous close
$20.61
52W high
$21.30
-1.99% from high
52W low
$17.49
89% of range
Market cap
$585.3M
Shares out
28.4M
Volume
249.6K
VWAP
$20.80
Price history computed in-house
1W
-1.99%
1M
+10.36%
SMA 50 $19.43 · above
SMA 200 $19.43 · above
52W position 89%
Veridion warehouse edge

Warehouse intelligence for FLGT.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

FLGT insider activity

Fulgent Genetics, Inc. Common Stock

Score
Coverage building
Pressure
Net selling
Filings
71
Buys / sells
0 / 71
Net value
-$6.0M
Insiders
4
Named filers
XJ
Xie Jian
Insider
Leadership
GH
Gao Hanlin
Insider
Leadership
HM
Hsieh Ming
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$6.0M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-032026-06-02Xie JianInsidersell$17.892,146367,605$38KSEC Form 4
2026-06-032026-06-02Gao HanlinInsidersell$17.891,688990,374$30KSEC Form 4
2026-06-032026-06-01Hsieh MingInsidersell$18.094,392893,293$79KSEC Form 4
2026-06-032026-06-01Kim PaulInsidersell$18.092,087362,545$38KSEC Form 4
2026-05-282026-05-27Xie JianInsidersell$17.601,201369,751$21KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 66 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

FLGT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FLGT in this window.
Lobbying spend

FLGT lobbying filings, year to date.

Registered lobbying filings matched to Fulgent Genetics, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FLGT in this window.
Latest news · FLGT
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for FLGT.
Options
Sovereign unlock shows live options positioning for FLGT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.